FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 1220874 · Received October 29, 2008

Report

Report Number
3004464228-2008-00273
Event Type
Malfunction
Date Received
October 29, 2008
Date of Event
October 2, 2008
Report Date
October 2, 2008
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WILL NOT BE RETURNED SO NO EVALUATION IS POSSIBLE. THE CUSTOMER NOTICED A "CRACKING" NOISE DURING THE FILL PROCESS INDICATES A PROBABLE PROBLEM WITH THE RETAINER THAT ALLOWED A COMPONENT TOO MOVE RESULTING IN DAMAGE. THIS DAMAGE PREVENTED THE PLUNGER FROM ADVANCING. THE USER WOULD HAVE BEEN AWARE OF A PROBLEM DURING THE FILL PROCESS. THERE IS RESISTANCE FELT IN FILLING THE POD WITH INSULIN AND A DISTINCT "CRACKLING" NOISE RESULTING FROM STRIPPING THE THREADS OF THE COMPONENT WHEN OVER-PRESSURIZED. THE OMNIPOD USER GUIDE STATES: "WARNING: NEVER USE A POD IF, DURING FILL, YOU DETECT ANY CRACKLING NOISE OR RESISTANCE WHILE DEPRESSING THE PLUNGER OF THE FILL SYRINGE. USING A POD WITH THESE CONDITIONS COULD RESULT IN UNDER-DELIVERY OF INSULIN." THE USER IS ALSO INSTRUCTED IN THE USER GUIDE TO MONITOR BLOOD GLUCOSE LEVELS FREQUENTLY. BY FOLLOWING THESE RECOMMENDATIONS, THE USER BECAME AWARE OF THEIR HIGH BLOOD GLUCOSE AND STARTED A NEW POD OR BACKUP THERAPY IF NEEDED.

Description of Event or Problem · 1

CUSTOMER CALLED TO REPORT A POD THAT WAS HARD TO FILL AND HE HEARD CRACKLING NOISES DURING FILL. CUSTOMER ACTIVATED THE POD ANYWAY AND DURING POD WEAR, CUSTOMER RECEIVED BLOOD GLUCOSE (BG) READINGS OF "HI" AND HAD SEVERE HYPERGLYCEMIC SYMPTOMS EVEN AFTER SEVERAL INSULIN BOLUSES. REVIEWED LABELLING INSTRUCTIONS WITH THE CUSTOMER. NO FURTHER ISSUES WERE IDENTIFIED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L11644

Patients

Seq Age Sex Outcome Treatment
1 41 YR Other